MMRF-CoMMpass Data Integration and Analysis for Identifying Prognostic Markers.

Multiple Myeloma (MM) is the second most frequent haematological malignancy in the world although the related pathogenesis remains unclear. The study of how gene expression profiling (GEP) is correlated with patients’ survival could be important for understanding the initiation and progression of MM.